BioStem Technologies, Inc.
BSEM
$11.26
-$0.6979-5.84%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.48M | 6.74M | 5.18M | 5.18M | 3.26M |
| Total Depreciation and Amortization | 78.10K | 99.30K | 50.90K | 50.90K | 51.90K |
| Total Amortization of Deferred Charges | 38.20K | 153.10K | 25.90K | 25.90K | 32.00K |
| Total Other Non-Cash Items | 1.96M | -2.37M | 4.73M | 4.73M | 3.28M |
| Change in Net Operating Assets | -2.48M | 4.83M | -3.68M | -3.68M | -6.07M |
| Cash from Operations | 4.07M | 9.46M | 6.30M | 6.30M | 554.20K |
| Capital Expenditure | -164.70K | -122.80K | -160.00K | -160.00K | -12.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -1.25M | -- | -- | -- |
| Cash from Investing | -164.70K | -1.37M | -160.00K | -160.00K | -12.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -101.80K | -143.50K | -212.50K | -212.50K | -388.00K |
| Issuance of Common Stock | 33.30K | 100.00K | 0.00 | 0.00 | 250.00K |
| Repurchase of Common Stock | -- | 0.00 | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -68.50K | -43.50K | -212.50K | -212.50K | -138.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | -- |
| Net Change in Cash | 3.84M | 8.04M | 5.93M | 5.93M | 403.80K |